Modelled DT Structure
Method: homology modeling
Template PDB: 5VRF_A; 2ENK_A
Identity: 25.806% ; 100%
Minimized Score: -738.414 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0277 | ||||
Gene Name | SLC30A9 | ||||
Protein Name | Zinc transporter 9 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 5VRF_A; 2ENK_A Identity: 25.806% ; 100% Minimized Score: -738.414 kcal/mol Detail: Structure Info |
||||
Synonyms | BILAPES; C4orf1; GAC63; HuEL; Human embryonic lung protein; SLC30A9; Solute carrier family 30 member 9; ZNT9; ZnT-9 | ||||
DT Family | Cation Diffusion Facilitator (CDF) Family ; | ||||
Tissue Specificity | Ubiquitously expressed in fetal and adulttissues and cancer cell lines. | ||||
Function | This transporter acts as a zinc transporter involved in intracellular zinc homeostasis. | ||||
Endogenous Substrate(s) | Zn2+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
References | |||||
1 | SLC30A9 mutation affecting intracellular zinc homeostasis causes a novel cerebro-renal syndrome. Brain. 2017 Apr 1;140(4):928-939. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.